Amarin and HEXAL in formulation deal
Sweden's Amarin Development has been commissioned by GEA Farmaceutisk Fabrik, a Danish subsidiary of German pharmaceutical company HEXAL, to develop a formulation of one of its candidate compounds.
Archives for May 25, 2003
New flu vaccine process from Solvay
Belgian pharmaceutical and chemicals firm Solvay expects to launch a new version of its Influvac brand flu vaccine, based on a novel cell-based production process, in 2005. The speed of the new process means that a vaccine can be produced extremely...